Literature DB >> 28249647

A clinicopathologic study on SS18 fusion positive head and neck synovial sarcomas.

Adepitan A Owosho1, Cherry L Estilo1, Evan B Rosen1, SaeHee K Yom1, Joseph M Huryn1, Cristina R Antonescu2.   

Abstract

OBJECTIVE: To determine clinicopathologic factors on survival in patients with head and neck synovial sarcoma. PATIENTS AND METHODS: We retrospectively identified patients with molecularly confirmed synovial sarcomas of the head and neck (SS-HN), either by the presence of SS18-SSX fusion transcript by RT-PCR or SS18 gene rearrangement by FISH, who were managed at our institution over a 20-year period (1996-2015). Kaplan-Meier survival analysis and log-rank test were performed to evaluate variables related to disease specific survival (DSS). Fisher exact test was performed to evaluate variables related to local recurrence.
RESULTS: Thirty-four patients (20 males and 14 females, mean of 31years) with SS18-SSX fusion-positive SS-HN were identified. The parapharyngeal region of the neck was the most common site. The mean tumor size was 4.8cm (0.8-10cm). Two-thirds (n=23) of cases had a monophasic histology. The 2, 5 and 10-year DSS rates were 97%, 79% and 68%. The 5-year DSS rates for the adult/pediatric cohort were 74%/88%. Recurrence showed significant effect on DSS (p=0.021). There was no significant effect on DSS with age, therapy modality, tumor site, surgical margin, tumor size (⩽5cm vs. >5cm) and histopathologic subtype. Tumor site (i.e. skull base/paranasal sinus region) was associated with local recurrence (p=0.003).
CONCLUSION: In our cohort DSS rate was associated with recurrence. Tumors located in the skull base/paranasal sinus region were associated with a higher rate of local recurrence. Thus appropriate selection of high risk patients who can benefit from multimodality therapies might improve survival.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Head and neck sarcomas; SS18-SSX; Synovial sarcoma; t(X;18)

Mesh:

Substances:

Year:  2017        PMID: 28249647      PMCID: PMC5640264          DOI: 10.1016/j.oraloncology.2016.12.021

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  23 in total

1.  The SYT-SSX1 variant of synovial sarcoma is associated with a high rate of tumor cell proliferation and poor clinical outcome.

Authors:  G Nilsson; B Skytting; Y Xie; B Brodin; R Perfekt; N Mandahl; J Lundeberg; M Uhlén; O Larsson
Journal:  Cancer Res       Date:  1999-07-01       Impact factor: 12.701

Review 2.  Fusions of the SYT and SSX genes in synovial sarcoma.

Authors:  M Ladanyi
Journal:  Oncogene       Date:  2001-09-10       Impact factor: 9.867

3.  TLE1 as a diagnostic immunohistochemical marker for synovial sarcoma emerging from gene expression profiling studies.

Authors:  Jefferson Terry; Tsuyoshi Saito; Subbaya Subramanian; Cindy Ruttan; Cristina R Antonescu; John R Goldblum; Erinn Downs-Kelly; Christopher L Corless; Brian P Rubin; Matt van de Rijn; Marc Ladanyi; Torsten O Nielsen
Journal:  Am J Surg Pathol       Date:  2007-02       Impact factor: 6.394

4.  Factors Associated With Survival in Patients With Synovial Cell Sarcoma of the Head and Neck: An Analysis of 167 Cases Using the SEER (Surveillance, Epidemiology, and End Results) Database.

Authors:  Jon Mallen-St Clair; Armin Arshi; Elliot Abemayor; Maie St John
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2016-06-01       Impact factor: 6.223

Review 5.  Molecular mechanisms underlying human synovial sarcoma development.

Authors:  N R dos Santos; D R de Bruijn; A G van Kessel
Journal:  Genes Chromosomes Cancer       Date:  2001-01       Impact factor: 5.006

6.  Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients.

Authors:  Marc Ladanyi; Cristina R Antonescu; Denis H Leung; James M Woodruff; Akira Kawai; John H Healey; Murray F Brennan; Julia A Bridge; James R Neff; Frederic G Barr; Jeffrey D Goldsmith; John S J Brooks; John R Goldblum; Syed Z Ali; Janet Shipley; Colin S Cooper; Cyril Fisher; Björn Skytting; Olle Larsson
Journal:  Cancer Res       Date:  2002-01-01       Impact factor: 12.701

Review 7.  Sarcomas of the head and neck region.

Authors:  Erich M Sturgis; Bryan O Potter
Journal:  Curr Opin Oncol       Date:  2003-05       Impact factor: 3.645

8.  Synovial sarcoma of the head and neck.

Authors:  R P Bukachevsky; R L Pincus; F G Shechtman; E Sarti; P Chodosh
Journal:  Head Neck       Date:  1992 Jan-Feb       Impact factor: 3.147

9.  Histologic grade, but not SYT-SSX fusion type, is an important prognostic factor in patients with synovial sarcoma: a multicenter, retrospective analysis.

Authors:  Louis Guillou; Jean Benhattar; Françoise Bonichon; Gabrielle Gallagher; Philippe Terrier; Edouard Stauffer; Nicolas de Saint Aubain Somerhausen; Jean-Jacques Michels; Gernot Jundt; Dominique Ranchère Vince; Sophia Taylor; Muriel Genevay; Françoise Collin; Martine Trassard; Jean-Michel Coindre
Journal:  J Clin Oncol       Date:  2004-09-13       Impact factor: 44.544

10.  Synovial sarcomas of the head and neck.

Authors:  R Carrillo; J L Rodriguez-Peralto; J G Batsakis
Journal:  Ann Otol Rhinol Laryngol       Date:  1992-04       Impact factor: 1.547

View more
  4 in total

1.  BCOR-CCNB3 Fusion Positive Sarcomas: A Clinicopathologic and Molecular Analysis of 36 Cases With Comparison to Morphologic Spectrum and Clinical Behavior of Other Round Cell Sarcomas.

Authors:  Yu-Chien Kao; Adepitan A Owosho; Yun-Shao Sung; Lei Zhang; Yumi Fujisawa; Jen-Chieh Lee; Leonard Wexler; Pedram Argani; David Swanson; Brendan C Dickson; Christopher D M Fletcher; Cristina R Antonescu
Journal:  Am J Surg Pathol       Date:  2018-05       Impact factor: 6.394

2.  A Clinicopathologic Study of Head and Neck Malignant Peripheral Nerve Sheath Tumors.

Authors:  Adepitan A Owosho; Cherry L Estilo; Joseph M Huryn; Ping Chi; Cristina R Antonescu
Journal:  Head Neck Pathol       Date:  2017-07-31

3.  A case of a 22-year-old man with primary synovial sarcoma of the parapharyngeal space with an AR somatic mutation: A case report and review of the literature.

Authors:  He Jiang; Ge Ma; Zunzhen Nie; Jin Zhu; Qingguo Yan; Hongzhang Chen; Haiyan Nan; Ying Guo
Journal:  SAGE Open Med Case Rep       Date:  2022-01-08

4.  Prognostic factors for laryngeal sarcoma and nomogram development for prediction: a retrospective study based on SEER database.

Authors:  Jia Gu; Zhifan Zuo; Lei Sun; Li Li; Ning Zhao
Journal:  Ann Transl Med       Date:  2020-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.